Renal dysfunction and clinical outcomes of patients undergoing ICD and CRTD implantation: Data from the Israeli ICD registry

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 9, 2014, Pages 990-997

  Eisen, Alon ^a   Suleiman, Mahmoud ^b   Strasberg, Boris ^a   Sela, Ron ^c   Rosenheck, Shimon ^d   Freedberg, Nahum A ^e   Geist, Michael ^f   Ben Zvi, Shlomit ^g   Goldenberg, Ilan ^g   Glikson, Michael ^g   Haim, Moti ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c WESTERN GALILEE HOSPITAL   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e HAEMEK MEDICAL CENTER   (Israel)

^f WOLFSON MEDICAL CENTER   (Israel)

^g SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cardiac resynchronization therapy; Chronic kidney disease; Heart failure; Implantable cardioverter defibrillator; Renal insufficiency

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CAUSE OF DEATH; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISRAELI; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PREVALENCE; PROSPECTIVE STUDY; ADVERSE EFFECTS; AGED; CARDIAC RESYNCHRONIZATION THERAPY; ISRAEL; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; ISRAEL; KIDNEY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84908118693     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12442     Document Type: Article

References (33)

1. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
2. Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J: Reduced kidney function as a risk factor for incident heart failure: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007;18:1307-1315.
3. Go AS, Chertow GM, Fan D,McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
4. ShlipakMG,Fried LF,Cushman M, ManolioTA, PetersonD, Stehman- Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease. JAMA 2005;293:1737-1745.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
7. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
8. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
9. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigator: Cardiac-resynchronization therapy for mildto- moderate heart failure. N Engl J Med 2010;363:2385-2395.
10. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
11. Abraham WT, Fisher AWG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group: Multicenter InSync ICD randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CAREHF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
13. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, Case RB; Multicenter Automatic Defibrillator Implantation Trial-II Investigators: Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-490.
14. Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD: Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-213.
15. Turakhia MP, Varosy PD, Lee K, Tseng ZH, Lee R, Badhwar N, Scheinman M, Lee BK, Olgin JE: Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2007;30:377-384.
16. Sakhuja R, Keebler M, Lai TS, Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL: Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009;103:735-741.
17. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R: Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006;3:1196-1201.
18. Hiremath S, Punnam SR, Brar SS, Goyal SK, Gardiner JC, Shah AJ, Thakur RK: Implantable defibrillators improve survival in end-stage renal disease: Results from a multi-center registry. Am J Nephrol 2010;32:305-310.
19. Aggarwal A,Wang Y, Rumsfeld JS,Curtis JP,Heidenreich PA:Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009;6:1565-1571.
20. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA: Benefit of primary prevention implantable cardioverterdefibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol 2008;19:1275-1280.
21. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-596.
22. Damman K, Van Deursen DM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009 7:582-588.
23. Pun PH, Smarz TR, Honeycutt EF, ShawLK,Al-Khatib SM,Middleton JP: Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009;76:652-658.
24. Richardson M, Freemantle N, CalvertMJ, Cleland JGF, Tavazzi L: Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: A predefined analysis from the CARE-HF trial. Eur Heart J 2007;28:1827- 1834.
25. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F: Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-2772.
26. Fung JWH, Szeto CC, Chan JYS, Zhang Q, Chan HC, Yip GW, Yu CM: Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 2007;122:10-16.
27. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA: Cardiorenal interactions: Insights from the ESCAPE Trial. J Am Coll Cardiol 2008;51:1268-1274.
28. Cowburn PJ, Patel H, Pipes RR, Parker JD: Contrast nephropathy post cardiac resynchronization therapy: An under-recognized complication with important morbidity. Eur J Heart Fail 2005;7:899-903.
29. Boerrigter G, Costello-Boerrigter LC, Abraham WT, Sutton MG, Heublein DM, Kruger KM, Hill MR, McCullough PA, Burnett JC Jr: Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Failure 2008;14:539-546.
30. Inage T,Yoshida T, Hiraki T, OheM, Takeuchi T,NagamotoY, Fukuda Y, Gondo T, Imaizumi T: Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Europace 2008;10:379-383.
31. Nagele H, Azizi M, Castel MA: Hemodynamic changes during cardiac resynchronization therapy. Clin Cardiol 2007;30:141-143.
32. Hamdan MH, Barbera S, Kowal RC, Page RL, Ramaswamy K, Joglar JA, Karimkhani V, Smith ML: Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:1047-1051.
33. Tarquini R, Guerra CT, Porciani MC, Michelucci A, Padeletti M, Ricciardi G, Chiostri M, Jelic S, Padeletti L: Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure. Cardiology 2009;16:545-552.